Trial intelligence / Profile preview

MOP, Prostaglandin E1 and Calcitriol Injections in Accelerating Orthodontic Tooth Movement

NCT07842120Phase 2Recruiting

Start
Apr 2026
Primary completion
Dec 2026
Countries
1
01

Overview

Phase 2, randomised trial of Vasostenoon and calcitriol in dental crowding (4 arms). Primary endpoint: Orthodontic Tooth Movement at 6 months. Started Apr 2026; status: recruiting.

02

Drugs

Vasostenooncalcitriol
03

Conditions

dental crowding

Beyond the preview

Go deeper on NCT07842120.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07842120.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call